Lataa...
Clinical trial of clarithromycin for lepromatous leprosy.
Clarithromycin was administered to nine previously untreated lepromatous leprosy patients. Patients received two 1,500-mg doses on the first day, followed by 7 days of no treatment, in order to evaluate the potential efficacy of intermittent therapy. Patients then received 1,000 mg daily for 2 weeks...
Tallennettuna:
| Julkaisussa: | Antimicrob Agents Chemother |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Microbiology (ASM)
1994
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284490/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8203847/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.3.515 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|